CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Nautilus Biotechnology, Inc. - NAUT CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 1.50-5.07
平均交易量（10 天） 210.16K
平均交易量（3 个月) 2.72M
市值 313.42M
市盈率 -100.00K
流通股 124.87M
收入 N/A
EPS -0.46
股息（收益率 %） N/A
贝塔 -100.00K
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Nautilus Biotechnology, Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019
总收入 0 0 0 0
总营业费用 63.618 50.498 15.744 10.11
销售/一般/行政费用，总计 25.946 21.146 3.312 1.622
研究与开发 36.472 28.352 12.432 8.488
营业收入 -63.618 -50.498 -15.744 -10.11
其他，净值 -0.122 0.183 0.125 0.492
税前净收入 -57.924 -50.315 -15.619 -9.618
税后净收入 -57.924 -50.315 -15.619 -9.618
未计算非常项目前的净收益 -57.924 -50.315 -15.619 -9.618
净收入 -57.924 -50.315 -15.619 -9.618
普通股股东可获收益 (不含非经常性项目) -57.924 -50.315 -15.619 -9.618
普通股股东可获收益 (含非經常性項目) -57.924 -50.315 -15.619 -9.618
摊薄净收入 -57.924 -50.315 -15.619 -9.618
摊薄后加权平均股 124.59 124.303 124.094 124.094
扣除特别项目的每股摊薄盈利 -0.46492 -0.40478 -0.12586 -0.07751
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.46492 -0.40478 -0.12586 -0.07751
Depreciation / Amortization 1.2 1
利息收入（费用），非经营净值 5.816
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
总收入 0 0 0 0 0
总营业费用 16.304 15.82 15.472 16.022 16.816
销售/一般/行政费用，总计 6.717 6.249 6.616 6.364 6.923
研究与开发 9.587 9.571 8.856 9.658 9.893
营业收入 -16.304 -15.82 -15.472 -16.022 -16.816
其他，净值 0.009 -0.132 0.783 0.259 0.127
税前净收入 -13.409 -14.063 -14.689 -15.763 -16.689
税后净收入 -13.409 -14.063 -14.689 -15.763 -16.689
未计算非常项目前的净收益 -13.409 -14.063 -14.689 -15.763 -16.689
净收入 -13.409 -14.063 -14.689 -15.763 -16.689
普通股股东可获收益 (不含非经常性项目) -13.409 -14.063 -14.689 -15.763 -16.689
普通股股东可获收益 (含非經常性項目) -13.409 -14.063 -14.689 -15.763 -16.689
摊薄净收入 -13.409 -14.063 -14.689 -15.763 -16.689
摊薄后加权平均股 124.792 124.651 124.494 124.419 124.303
扣除特别项目的每股摊薄盈利 -0.10745 -0.11282 -0.11799 -0.12669 -0.13426
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.10745 -0.11282 -0.11799 -0.12669 -0.13426
利息收入（费用），非经营净值 2.886 1.889
  • 年度
  • 每季度
2021 2020 2019
流动资产总额 349.222 77.659 16.964
现金和短期投资 345.729 76.742 16.659
现金等价物 185.619 36.607 0.595
短期投资 160.11 40.135 16.064
Prepaid Expenses 3.493 0.917 0.305
Total Assets 398.45 85.011 18.542
Property/Plant/Equipment, Total - Net 31.86 6.213 1.119
Property/Plant/Equipment, Total - Gross 33.854 7.498 1.868
Accumulated Depreciation, Total -1.994 -1.285 -0.749
Other Long Term Assets, Total 0.997 1.139 0.459
Total Current Liabilities 5.812 3.018 0.49
Accounts Payable 1.723 0.47 0.289
Accrued Expenses 4.089 2.548 0.201
Notes Payable/Short Term Debt 0 0 0
Total Liabilities 34.874 6.314 0.49
Total Long Term Debt 0 0 0
Other Liabilities, Total 29.062 3.296 0
Total Equity 363.576 78.697 18.052
Preferred Stock - Non Redeemable, Net 0 108.418 32.561
Common Stock 0.012 0.001 0.001
Additional Paid-In Capital 444.388 0.6 0.189
Retained Earnings (Accumulated Deficit) -80.64 -30.325 -14.706
Other Equity, Total -0.184 0.003 0.007
Total Liabilities & Shareholders’ Equity 398.45 85.011 18.542
Total Common Shares Outstanding 124.303 124.094 124.094
Long Term Investments 16.371
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 327.065 349.222 352.222 374.628 69.445
现金和短期投资 324.117 345.729 347.345 373.144 67.837
现金等价物 188.622 185.619 190.241 288.387 51.803
短期投资 135.495 160.11 157.104 84.757 16.034
Prepaid Expenses 2.948 3.493 4.877 1.484 1.608
Total Assets 384.673 398.45 385.347 393.275 76.148
Property/Plant/Equipment, Total - Net 31.693 31.86 5.731 2.769 2.889
Property/Plant/Equipment, Total - Gross 33.968 33.854 7.772 4.533 4.388
Accumulated Depreciation, Total -2.275 -1.994 -2.041 -1.764 -1.499
Other Long Term Assets, Total 0.997 0.997 0.767 0.612 3.814
Total Current Liabilities 6.406 5.812 4.209 3.231 4.525
Accounts Payable 1.487 1.723 1.498 1.229 2.12
Accrued Expenses 4.919 4.089 2.711 2.002 2.405
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 34.964 34.874 7.5 3.231 4.525
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 28.558 29.062 3.291 0 0
Total Equity 349.709 363.576 377.847 390.044 71.623
Preferred Stock - Non Redeemable, Net 0 0 108.418
Common Stock 0.012 0.012 0.012 0.012 0.001
Additional Paid-In Capital 446.654 444.388 441.795 439.489 1.936
Retained Earnings (Accumulated Deficit) -96.403 -80.64 -63.951 -49.447 -38.734
Other Equity, Total -0.554 -0.184 -0.009 -0.01 0.002
Total Liabilities & Shareholders’ Equity 384.673 398.45 385.347 393.275 76.148
Total Common Shares Outstanding 124.457 124.303 124.094 124.094 124.094
Long Term Investments 24.918 16.371 26.627 15.266
  • 年度
  • 每季度
2021 2020 2019
净收入/起跑线 -50.315
经营活动产生的现金 -39.241
经营活动产生的现金 1.019
非现金物品 10.077
营运资金的变化 -0.022
投资活动产生的现金 -138.964
资本支出 -2.269
其他投资现金流量项目，总计 -136.695
融资活动产生的现金 327.447
融资现金流项目 327.28
股票的发行（报废），净额 0.167
现金净变化 149.242
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -15.763 -50.315 -33.626 -19.122 -8.409
Cash From Operating Activities -12.335 -39.241 -28.722 -14.545 -6.253
Cash From Operating Activities 0.281 1.019 0.756 0.479 0.214
Non-Cash Items 2.661 10.077 6.811 4.129 1.864
Changes in Working Capital 0.486 -0.022 -2.663 -0.031 0.078
Cash From Investing Activities 15.182 -138.964 -145.028 -61.048 23.518
Other Investing Cash Flow Items, Total 15.663 -136.695 -143.745 -60.035 23.518
Cash From Financing Activities 0.156 327.447 327.384 327.373 -2.069
Financing Cash Flow Items 0 327.28 327.28 327.327 -2.069
Net Change in Cash 3.003 149.242 153.634 251.78 15.196
Capital Expenditures -0.481 -2.269 -1.283 -1.013
Issuance (Retirement) of Stock, Net 0.156 0.167 0.104 0.046
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Mallick (Parag) Individual Investor 16.5616 20679892 200000 2022-04-18 LOW
Patel (Sujal M) Individual Investor 13.7018 17108999 0 2023-02-27 LOW
Perceptive Advisors LLC Private Equity 7.2967 9111151 0 2022-12-31 MED
Cercano Management LLC Investment Advisor 5.7445 7172985 7172985 2022-12-31
Vulcan Capital Management Inc Corporation 5.7445 7172985 0 2022-04-18
Madrona Venture Group, LLC Venture Capital 4.8218 6020770 0 2022-12-31 LOW
ARYA Sciences Holdings III Corporation 3.3207 4146500 3647500 2022-04-18
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.1231 2651020 144356 2022-12-31 LOW
Comprehensive Financial Management LLC Investment Advisor 1.7816 2224619 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.7422 2175376 -1313 2022-12-31 LOW
Bain Capital Life Sciences Investors, LLC Investment Advisor 1.6017 2000000 0 2022-12-31 LOW
Nazem (Farzad) Individual Investor 1.5121 1888146 0 2022-04-18 LOW
Tikvah Management LLC Hedge Fund 1.1924 1488895 0 2022-12-31 LOW
Amazon.com Inc Investment Advisor 1.1669 1457055 0 2022-12-31 LOW
ArchPoint Investors, LLC Investment Advisor 1.1609 1449551 0 2022-12-31 LOW
Andreessen Horowitz Venture Capital 1.0859 1355911 -16298006 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7695 960868 5799 2022-12-31 LOW
Rubric Capital Management LP Hedge Fund 0.5987 747607 0 2022-12-31 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.5624 702204 49879 2022-12-31 LOW
RTW Investments L.P. Investment Advisor/Hedge Fund 0.4805 600000 0 2022-12-31 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Nautilus Biotechnology, Inc. Company profile

关于 Nautilus Biotechnology Inc.

Nautilus 生物技术公司是一家处于发展阶段的生命科学公司。 该公司从事创建一个平台技术，用于量化和解锁人类蛋白质组的复杂性。 公司专注于通过普及蛋白质组的使用来改变蛋白质组学领域，并使整个人类健康和医学取得根本性的进步。 其平台的端到端解决方案由蛋白质组分析系统、耗材和软件组成。 公司正在开发一个单分子仪器的原型--蛋白质组分析系统。 公司的蛋白质组分析平台利用纳米制造的单分子蛋白质阵列、多周期成像和机器学习分析来识别和测量具有灵敏度和规模的蛋白质组。

Industry: Biotechnology & Medical Research (NEC)

2701 Eastlake Ave East
Suite 202
SEATTLE
WASHINGTON 98102
US

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,809.20 Price
+0.100% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

Oil - Crude

70.79 Price
+1.940% 1D Chg, %
多头隔夜费 -0.0193%
空头隔夜费 -0.0026%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.49 Price
+9.600% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00482

Gold

1,955.09 Price
-1.190% 1D Chg, %
多头隔夜费 -0.0180%
空头隔夜费 0.0098%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易